Tubal origin of ovarian endometriosis and clear cell and endometrioid carcinoma.
article
OA: green
CC0
⤵ 18 in-corpus citations
Abstract
Current research has strongly proposed that contrary to prior beliefs, many ovarian epithelial cancers (OECs) do not, as their name suggests, originate in the ovaries. Recent findings regarding both high-grade and low-grade serous carcinomas has implicated the fallopian tube as a cell source for these OECs, but until now, there has been little insight into the cellular source for clear cell and endometrioid carcinomas. In this commentary review article, we aimed to discuss the new findings that support the possible contribution from the fallopian tube in clear cell and endometrioid carcinomas. Specifically, we have provided results that showcased ovarian surface epithelia (OSE) and ovarian epithelial inclusions (OEIs) as having mesothelial and tubal origins and have strongly recognized the secondary müllerian system and the ability for tubal epithelia to implant upon the ovarian surface as contributing to fallopian tube-derived OEIs (F-OEIs). We have provided initial indications of these F-OEIs and their relationship to endometriosis and then clear cell and endometrioid carcinomas and subsequently offer our new proposal of a probable tubal origin. This new proposal is a paradigm that drastically changes the understanding behind the origin of these OECs and has significant clinical implications in the near future.
My notes (saved in your browser only)
Condition tags
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (38)
- Allelotyping of endometriosis with adjacent ovarian carcinoma reveals evidence of a common lineage. via openalex
- <b>Ovarian atypical endometriosis: its close association with malignant epithelial tumours</b> via openalex
- Endometriosis and ovarian cancer via openalex
- Endosalpingiosis and chronic pelvic pain. via openalex
- Histologic Transformation of Benign Endometriosis to Early Epithelial Ovarian Cancer via openalex
- <i>ARID1A</i> Mutations in Endometriosis-Associated Ovarian Carcinomas via openalex
- Initial Endometriosis Showing Direct Morphologic Evidence of Metaplasia in the Pathogenesis of Ovarian Endometriosis via openalex
- Malignant external endometriosis. A case of adenocarcinoma of umbilical endometriosis. via openalex
- Metastatic or Embolic Endometriosis, due to the Menstrual Dissemination of Endometrial Tissue into the Venous Circulation. via openalex
- Molecular genetic evidence that endometriosis is a precursor of ovarian cancer via openalex
- Müllerianosis. via openalex
- Ovarian carcinoma arising in endometriosis via openalex
- Peritoneal endometriosis due to the menstrual dissemination of endometrial tissue into the peritoneal cavity via openalex
- Prevalence of Endometriosis in Ovarian Cancer via openalex
- Retrograde menstruation in healthy women and in patients with endometriosis. via openalex
- The Secondary Müllerian System Revisited via openalex
- Tumors and Pseudotumors of the Secondary Müllerian System: Review With Emphasis on Cross-Sectional Imaging Findings via openalex
- W2052204304 via openalex
- W2010317565 via openalex
- W2070369494 via openalex
- W2044464259 via openalex
- W2075053675 via openalex
- W2039004437 via openalex
- W2096822414 via openalex
- W2013107316 via openalex
- W2120347875 via openalex
- W2121172394 via openalex
- W2121741947 via openalex
- W2122634638 via openalex
- W1975141727 via openalex
- W2132808328 via openalex
- W1969111307 via openalex
- W2158803808 via openalex
- W2012008388 via openalex
- W2017209612 via openalex
- W1671745519 via openalex
- W4211081176 via openalex
- W2014013992 via openalex
Cited by (18)
- The “Road” to Malignant Transformation from Endometriosis to Endometriosis-Associated Ovarian Cancers (EAOCs): An mTOR-Centred Review 2024
- Characteristics and Prognosis of Ovarian Pure Clear Cell Carcinoma: A Retrospective Experience of 136 Patients 2023
- The Association between Deoxyribonucleic Acid Hypermethylation in Intron VII and Human Leukocyte Antigen-C∗07 Expression in Patients with Endometriosis 2023
- Vaginal Endosalpingiosis: A Case Report and Literature Review 2022
- Differential Expression of Long Non-coding Ribonucleic Acid (RNA) Genes in Endometriosis-associated Ovarian Cancer (EAOC): A Pilot Meta-analysis for Pathological Insights and Potential Diagnostic Biomarker Identification 2022
- Diagnosis and treatment of tubal endometriosis in women undergoing laparoscopy: A case series from a single hospital 2022
- Endometriosis: not just a benign disease 2022
- Tubal Endometriosis: From Bench to Bedside, A Scoping Review 2022
- Folate Receptor Alpha Expression in Fallopian Tube: Further Evidence Supporting Tubal Contribution of “Ovarian” Endometriosis 2021
- Novel clinical and morphological predictors of malignancy in patients with ovarian endometrioid cysts 2021
- Increased association of ovarian cancer in women with histological proven endosalpingiosis 2020
- Endometriosis and Endometriosis-Associated Tumors 2019
- Novel CTCF mutations in Chinese patients with ovarian endometriosis 2018
- Unraveling endometriosis-associated ovarian carcinomas using integrative proteomics 2018
- Unraveling endometriosis-associated ovarian carcinomas using integrative proteomics 2018
- Epithelial-to-Mesenchymal Transition in the Female Reproductive Tract: From Normal Functioning to Disease Pathology 2017
- Caracterização morfológica da endometriose ovariana 2016
- Endosalpingiosis: More than just an incidental finding at the time of gynecologic surgery? 2016
Source provenance
- europepmc
- last seen: 2026-06-11T06:19:48.454388+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-05-13T22:17:52.213533+00:00
License: CC0
· commercial use OK